General Information of the Compound
| Compound ID |
CP0352191
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[[(3S)-piperidin-3-yl]methyl]-7-(1H-pyrazol-4-yl)pyrido[3,4-b]pyrazin-5-amine
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C16H19N7
|
||||||||||||||||||
| Molecular Weight |
309.377
|
||||||||||||||||||
| Canonical SMILES |
C(Nc1nc(cc2nccnc12)-c1cn[nH]c1)[C@H]1CCCNC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C16H19N7/c1-2-11(7-17-3-1)8-20-16-15-14(18-4-5-19-15)6-13(23-16)12-9-21-22-10-12/h4-6,9-11,17H,1-3,7-8H2,(H,20,23)(H,21,22)/t11-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
MTOXIGVDKCMGPO-NSHDSACASA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound